Pre-Approval Access to Rilpivirine Long Acting (RPV LA) Injectable Suspension for the Treatment of a Participant With Human Immunodeficiency Virus (HIV)-1 Infection
Clinical trial NCT03847376 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT03847376
- Sponsor
- Janssen Sciences Ireland UC
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.